Koibuchi Y - Search Results

1

Effect of FK409, a novel nitric oxide donor, on acute experimental myocardial ischemia.

Isono T, Sato N, Koibuchi Y, Sakai S, Yamamoto T, Ozaki R, Mori J, Kohsaka M, Ohtsuka M. Isono T, et al. Among authors: koibuchi y. Jpn J Pharmacol. 1993 Jul;62(3):315-24. doi: 10.1254/jjp.62.315. Jpn J Pharmacol. 1993. PMID: 8411778 Free article.

2

Vasorelaxant mechanism of the new vasodilator, FK409.

Isono T, Koibuchi Y, Sato N, Furuichi A, Nishii M, Yamamoto T, Mori J, Kohsaka M, Ohtsuka M. Isono T, et al. Among authors: koibuchi y. Eur J Pharmacol. 1993 Aug 15;246(3):205-12. doi: 10.1016/0922-4106(93)90032-5. Eur J Pharmacol. 1993. PMID: 7901040

3

Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.

Isono T, Sato N, Yamamoto T, Sawada T, Yamazaki S, Miura S, Furuichi A, Ozaki R, Koibuchi Y, Ohtsuka M. Isono T, et al. Among authors: koibuchi y. Eur J Pharmacol. 1994 Aug 1;260(2-3):163-8. doi: 10.1016/0014-2999(94)90333-6. Eur J Pharmacol. 1994. PMID: 7988640

4

Effects of nilvadipine on the cardiovascular system in experimental animals.

Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T, et al. Ohtsuka M, et al. Among authors: koibuchi y. Arzneimittelforschung. 1988 Nov;38(11):1605-18. Arzneimittelforschung. 1988. PMID: 3214444

5

Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency.

Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M. Yamamoto T, et al. Among authors: koibuchi y. J Urol. 1995 Dec;154(6):2174-8. J Urol. 1995. PMID: 7500484

6

Effects of nilvadipine, a new calcium entry blocker, on systemic blood pressure, cardiac hypertrophy and venous distensibility in spontaneously hypertensive rats.

Ohtsuka M, Sakai S, Miura S, Kurosaki M, Koibuchi Y, Ono T, Shibayama F. Ohtsuka M, et al. Among authors: koibuchi y. Arch Int Pharmacodyn Ther. 1989 Sep-Oct;301:228-45. Arch Int Pharmacodyn Ther. 1989. PMID: 2533860

7

Characteristics of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries.

Shibata S, Satake N, Sato N, Matsuo M, Koibuchi Y, Hester RK. Shibata S, et al. Among authors: koibuchi y. J Cardiovasc Pharmacol. 1991 Mar;17(3):508-18. doi: 10.1097/00005344-199103000-00022. J Cardiovasc Pharmacol. 1991. PMID: 1711615

8

Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.

Koibuchi Y, Sakai S, Miura S, Ono T, Shibayama F, Ohtsuka M. Koibuchi Y, et al. Atherosclerosis. 1989 Oct;79(2-3):147-55. doi: 10.1016/0021-9150(89)90119-6. Atherosclerosis. 1989. PMID: 2597224

9

Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.

Matsuo M, Koibuchi Y, Tomoi M, Ono T, Shibayama F, Ohtsuka M. Matsuo M, et al. Among authors: koibuchi y. Arzneimittelforschung. 1989 May;39(5):576-9. Arzneimittelforschung. 1989. PMID: 2757673

10

Expression and possible functional role of the beta3-adrenoceptor in human and rat detrusor muscle.

Fujimura T, Tamura K, Tsutsumi T, Yamamoto T, Nakamura K, Koibuchi Y, Kobayashi M, Yamaguchi O. Fujimura T, et al. Among authors: koibuchi y. J Urol. 1999 Feb;161(2):680-5. J Urol. 1999. PMID: 9915482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters